You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AURX Award Disclosure
Jorden David Emerson · SEC Form 4 · Filed Jul 2, 2026
Award
Calculated transaction value
$0
Jorden David Emerson CEO/CFO
AURX
Transaction date
Jun 29, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 3 days later
AURX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Option to purchase common stock on Common Stock
- Quantity / price
- 125,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001437749-26-022665
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$325K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nuo Therapeutics, Inc. AURX | Disposition | Jun 30, 2026 | $162.5K |
| Nuo Therapeutics, Inc. AURX | Exercise | Jun 30, 2026 | $0 |
| Nuo Therapeutics, Inc. AURX | Exercise | Jun 30, 2026 | $162.5K |
| Nuo Therapeutics, Inc. AURX Current | Award | Jun 29, 2026 | $0 |